Fluzoparib in Combination With Camrelizumab and Temozolomide in Advanced Melanoma
Clinical trial NCT05983237 · RECRUITING
Trial details
- NCT number
- NCT05983237
- Sponsor
- Jun Guo
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-15
- Primary completion
- 2026-12-31
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.